Author name: William Wickham

Expert in Pharmaceutical Distribution, Marketing, and Regulatory Affairs


William Wickham is a recognized leader in the pharmaceutical industry, known for his expertise in pharmaceutical distribution, marketing, digital marketing, and regulatory affairs.

He holds key positions as the CEO of Delta Medical, Managing Director at Social Marketing Initiatives, and Scientific Advisor at Maxima Health Research.

William Wickham

Key Roles

  • Delta Medical (CEO): Over 23 years, William has driven significant international market expansion, focusing on regions like Russia, Ukraine, and Eurasia. His strategic approach to pharmaceutical distribution has been crucial in launching new products.
  • Social Marketing Initiatives (Managing Director): With more than 22 years at this marketing agency, William has utilized digital marketing strategies effectively, particularly in the realm of social media, enhancing brand presence. He is also a founder of the pharmaceutical trade journal Mister Blister.
  • Maxima Health Research (Scientific Advisor): His 25 years at a Regulatory CRO, reflect his expertise in regulatory strategy, compliance, and dossier submission, especially in CIS countries. He demonstrates his dedication to regulatory excellence and adaptability in a complex, changing regulatory environment.

Expertise

  • International Market Expansion.
  • Pharmaceutical Distribution.
  • Digital Marketing and Social Media Strategy.
  • Pharmaceutical Industry Leadership.
  • Regulatory Affairs in CIS Countries.

Education

  • B.A. in International Relations, Bucknell University, Pennsylvania.
  • M.A. in Eurasian, Russian, and East European Studies, Georgetown University, Washington, DC.

Published Articles

Previous Speaking Engagements

  • Nicholas Hall OTC Conference in Luzern, Switzerland.
  • CEUTA Healthcare Alliance in Rome, Italy.
  • Adam Smith Pharmaceutical Conference in Istanbul, Turkey.
  • Marcus Evans Conference in Vienna, Austria.

Connect with William

LINKEDIN

An image of a division of a large pharmaceutical company

Sanofi Consumer Health Divestment: Transforming OTC Markets in Ukraine, Russia, and CIS

The pharmaceutical industry is no stranger to transformation. The recent trend of major companies divesting their consumer healthcare divisions marks a significant shift. Sanofi’s decision to spin off its consumer healthcare unit, now called Opella Healthcare, is the latest example of this realignment. Why Are Pharma Giants Divesting Consumer Healthcare Divisions? Why are big pharma […]

Read More »

doctor reviewing genetic analysis tablet computer functional medicine

Functional Medicine: Principles, Practices, and Criticisms

Functional medicine has emerged as a popular alternative approach to healthcare, gaining traction among doctors and pharmacists worldwide.  As chronic diseases continue to plague a significant portion of the adult population, with approximately 50% having at least one chronic condition and 25% suffering from two or more, the need for effective, long-term solutions has become […]

Read More »

Pharmacy Russia modern

Expanding Pharmacy Chains Consolidate Russian Market

Over the past few years, Russia has seen immense growth in its pharmacy industry led by the expansion of large pharmacy chains. As of 2023, there are over 77,000 pharmacies across Russia, up 4.6% from 2022. Pharmacy chains now account for 91.7% of total pharmacy revenue in the country. Russian Pharmacy Chains Consolidating Market Through […]

Read More »

Alcea logo

Acino Spins Off Embattled Russian Division into New Company Alcea

As war rages in Ukraine and tensions between Russia and the West escalate, Swiss pharmaceutical giant Acino International has made the strategic decision to spin-off its Russian division Acino Rus into a separate independent entity called Alcea. Acino had expanded in Russia since 2015, achieving double-digit growth in recent years largely driven by sales of […]

Read More »

Fruit

Understanding the Benefits of Extended Release Multivitamins

Did you know that the way your body absorbs vitamins and minerals can significantly impact their effectiveness? That’s where extended release multivitamins come in. These innovative supplements offer a more efficient and effective way to deliver essential nutrients to your body, ensuring you get the most out of your daily multivitamin. In this blog post, we’ll explore the benefits and risks of extended release multivitamins, explain how to choose the right product, and discuss the importance of bioavailability and absorption. So, let’s dive in and uncover the secrets behind these powerful health boosters.

Read More »

Molecular structure of phenylephrine

The Phenylephrine Paradox: What a U.S. FDA Decision Could Mean for Europe

In a move that could reverberate across the Atlantic, a U.S. FDA advisory panel has unanimously declared that oral phenylephrine, a common ingredient in over-the-counter (OTC) cold medications, is ineffective for relieving nasal congestion. This decision could have implications for European consumers and regulators, as phenylephrine is also a staple in many European cold remedies. […]

Read More »

Scroll to Top